ConductScience.org, home

Paper34375141

Why Are Patients Switching from Tenofovir Disoproxil Fumarate/Emtricitabine (Truvada) to Tenofovir Alafenamide/Emtricitabine (Descovy) for Pre-Exposure Prophylaxis?

D'Angelo AB and 4 others. AIDS Patient Care STDS, 2021. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. Why Are Patients Switching from Tenofovir Disoproxil Fumarate/Emtricitabine (Truvada) to Tenofovir Alafenamide/Emtricitabine (Descovy) for Pre-Exposure Prophylaxis? Papers, record 34375141. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34375141

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Why Are Patients Switching from Tenofovir Disoproxil Fumarate/Emtricitabine (Truvada) to Tenofovir Alafenamide/Emtricitabine (Descovy) for Pre-Exposure Prophylaxis?
PubMed
Journal
AIDS Patient Care STDS
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
1.91
iCite
Revised in PubMed
2022-08-02
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1D'Angelo ABAlexa Bhttps://orcid.org/0000-0001-5260-340X
2Westmoreland DADrew A
3Carneiro PBPedro Bhttps://orcid.org/0000-0002-4638-7824
4Johnson JJeremiah
5Grov CChristian

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-HIV AgentsMajor topic
HIV InfectionsMajor topic
Pre-Exposure ProphylaxisMajor topic
Adenine
Alanine
Cohort Studies
Emtricitabine
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Humans
Male
Tenofovir

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
UH3 AI133675NIAID NIH HHSUnited StatesUH3AI133675PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127540015Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study.BMJ2016https://conductscience.org/library/papers/27540015PubMed
220945262All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.Am J Bioeth2010https://conductscience.org/library/papers/20945262PubMed
332711800
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.
Lancet2020https://conductscience.org/library/papers/32711800PubMed
431742421Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Significantly Worsens the Lipid Profile in a Real-World Setting.AIDS Patient Care STDS2019https://conductscience.org/library/papers/31742421PubMed
527322350Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.JAMA Intern Med2016https://conductscience.org/library/papers/27322350PubMed
624210060Effectiveness of academic detailing to optimize medication prescribing behaviour of family physicians.J Pharm Pharm Sci2013https://conductscience.org/library/papers/24210060PubMed
722852138FDA paves the way for pre-exposure HIV prophylaxis.Lancet2012https://conductscience.org/library/papers/22852138PubMed
831412928Changing prescribing behaviours with educational outreach: an overview of evidence and practice.BMC Med Educ2019https://conductscience.org/library/papers/31412928PubMed
932654021Economic, Mental Health, HIV Prevention and HIV Treatment Impacts of COVID-19 and the COVID-19 Response on a Global Sample of Cisgender Gay Men and Other Men Who Have Sex with Men.AIDS Behav2021https://conductscience.org/library/papers/32654021PubMed
1031896287Maximizing Response Rates to Ads for Free At-Home HIV Testing on a Men-for-Men Geosocial Sexual Networking App: Lessons Learned and Implications for Researchers and Providers.Health Educ Behav2020https://conductscience.org/library/papers/31896287PubMed
1122636826Effect of physician payment disclosure laws on prescribing.Arch Intern Med2012https://conductscience.org/library/papers/22636826PubMed
1230515300How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP.J Virus Erad2018https://conductscience.org/library/papers/30515300PubMed
1327562781Two years of sunshine: has openness about payments reduced industry influence in healthcare?BMJ2016https://conductscience.org/library/papers/27562781PubMed
142104640Principles of educational outreach ('academic detailing') to improve clinical decision making.JAMA1990https://conductscience.org/library/papers/2104640PubMed
1527856120Gifts and influence: Conflict of interest policies and prescribing of psychotropic medications in the United States.Soc Sci Med2017https://conductscience.org/library/papers/27856120PubMed
1631182379Recruiting vulnerable populations to participate in HIV prevention research: findings from the Together 5000 cohort study.Ann Epidemiol2019https://conductscience.org/library/papers/31182379PubMed
1732729019Marketing of Tenofovir Disoproxil Fumarate (TDF) Lawsuits and Social Media Misinformation Campaigns' Impact on PrEP Uptake Among Gender and Sexual Minority Individuals.AIDS Behav2021https://conductscience.org/library/papers/32729019PubMed
1831931525Tenofovir Alafenamide for HIV Preexposure Prophylaxis: What Can We DISCOVER About Its True Value?Ann Intern Med2020https://conductscience.org/library/papers/31931525PubMed
1932702085Product Hopping-An Expensive and Wasteful Practice.JAMA Intern Med2020https://conductscience.org/library/papers/32702085PubMed
2027347468Patent cliff and strategic switch: exploring strategic design possibilities in the pharmaceutical industry.Springerplus2016https://conductscience.org/library/papers/27347468PubMed

See all 27 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
42989257Communication strategies for a future HIV vaccine: a qualitative study on experiences of research staff at the frontlines of recruiting for HIV vaccine clinical trials in the US South.AIDS Res Ther2026https://conductscience.org/library/papers/42989257PubMed
41324957Telemedicine Preexposure Prophylaxis Prescribing From a Large Online US Company.JAMA Netw Open2025https://conductscience.org/library/papers/41324957PubMed
40758923Insurance Denials And Cost Sharing For PrEP Among Sexual And Gender Minority People.Health Aff (Millwood)2025https://conductscience.org/library/papers/40758923PubMed
40323138Performance of a whole blood immunoassay for tenofovir detection and correlation with self-reported pre-exposure prophylaxis use in HIV-negative men who have sex with men interested in blood donation.Transfusion2025https://conductscience.org/library/papers/40323138PubMed
39636888Health care providers' decision-making and early adoption of tenofovir alafenamide for HIV preexposure prophylaxis: An inductive qualitative study.PLoS One2024https://conductscience.org/library/papers/39636888PubMed
39339960New Therapies and Strategies to Curb HIV Infections with a Focus on Macrophages and Reservoirs.Viruses2024https://conductscience.org/library/papers/39339960PubMed
39222182Integrated PrEP and STI Services for Transgender Women in Uganda: Qualitative Findings from a Randomized Trial.AIDS Behav2025https://conductscience.org/library/papers/39222182PubMed
39095331Long-Acting Injectable Pre-Exposure Prophylaxis Perceptions and Preferences Among Transgender and Nonbinary Young Adults in the United States.Qual Health Res2025https://conductscience.org/library/papers/39095331PubMed
38565913The landscape of small-molecule prodrugs.Nat Rev Drug Discov2024https://conductscience.org/library/papers/38565913PubMed
38352151Changes in Glomerular Filtration Rate After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Fumarate for Human Immunodeficiency Virus Preexposure Prophylaxis.Open Forum Infect Dis2024https://conductscience.org/library/papers/38352151PubMed
38075520Overcoming structural barriers to diffusion of HIV pre-exposure prophylaxis.J Med Access2023https://conductscience.org/library/papers/38075520PubMed
37695583Use of Tenofovir Alafenamide Fumarate for HIV Pre-Exposure Prophylaxis and Incidence of Hypertension and Initiation of Statins.JAMA Netw Open2023https://conductscience.org/library/papers/37695583PubMed
37457283Analysis of online user discussions on Reddit associated with the transition of use between HIV PrEP therapy.Front Public Health2023https://conductscience.org/library/papers/37457283PubMed
36880399Enzyme-Triggered l-α/d-Peptide Hydrogels as a Long-Acting Injectable Platform for Systemic Delivery of HIV/AIDS Drugs.Adv Healthc Mater2023https://conductscience.org/library/papers/36880399PubMed
36367995Preferences Across Pre-Exposure Prophylaxis Modalities Among Young Men Who Have Sex with Men in the United States: A Latent Class Analysis Study.AIDS Patient Care STDS2022https://conductscience.org/library/papers/36367995PubMed
36306520Validation of HIV Pre-Exposure Prophylaxis (PrEP) Medication Scales with Youth on PrEP: PrEP Confidence Scale and PrEP Difficulties Scale.AIDS Patient Care STDS2022https://conductscience.org/library/papers/36306520PubMed
35902080Health Departments and PrEP: A Missed Opportunity for Public Health.J Law Med Ethics2022https://conductscience.org/library/papers/35902080PubMed
35507322Dismantling Barriers and Transforming the Future of Pre-Exposure Prophylaxis Uptake in Young Black and Latinx Sexual Minority Men and Transgender Women.AIDS Patient Care STDS2022https://conductscience.org/library/papers/35507322PubMed
35337371Considerations and challenges for sex-aware drug repurposing.Biol Sex Differ2022https://conductscience.org/library/papers/35337371PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34375141

GET https://conductscience.org/api/papers/v1/34375141/references?page=2